You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Litigation Details for BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. v. ANOBRI PHARMACEUTICALS US, LLC (D.N.J. 2023)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. v. ANOBRI PHARMACEUTICALS US, LLC
The small molecule drugs covered by the patents cited in this case are ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , and ⤷  Sign Up .

Details for BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. v. ANOBRI PHARMACEUTICALS US, LLC (D.N.J. 2023)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 External link to document
2024-07-24 48 1 - Terminate Deadlines AND Order ANDAFFIRMATIVE DEFENSES REGARDING U.S. PATENT NOS. 7,284,474 AND 7,896,264 without prejudice. Signed … 18 December 2023 2:23-cv-03531 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.